IL3 and neoplasm: Our early studies using fibrosarcoma tumor models [20], [22] demonstrated that the expression of the IL-3 gene within tumors could enhance the immunogenicity of classically non-immunogenic tumors, leading to the development of long-term immunity even after the primary tumor was regressed by irradiation [20].